Back to APRE

Aprea Therapeutics, Inc. 8-K

Accession 0001104659-26-036821

Filing information

CIK
0001781983
Report date
2026-03-30
Filing date
2026-03-30
Form
8-K
Primary document
tm2610566d1_8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.